Structure diversity, synthesis, and biological activity of cyathane diterpenoids in higher fungi

Current Medicinal Chemistry

Volumn 22, Issue 19, 2015, Pages 2375-2391

  Tang, Hao Yu ^a   Yin, Xia ^a   Zhang, Cheng Chen ^a   Jia, Qian ^a   Gao, Jin Ming ^a,b  

^a NORTHWEST A F UNIVERSITY   (China)

^b BAOJI UNIVERSITY OF ARTS AND SCIENCES   (China)

Author keywords

Basidiomycete; Cyathane diterpenes; Enantioselective synthesis; Mushroom; Natural products; NGf synthesis inducers; Structure activity relationships

Indexed keywords

CYATHANE DITERPENOID; CYATHIN; CYATHIN B2; CYRNEINE A; DITERPENOID; EPISCABRONINE A; ERINANCINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; NERVE GROWTH FACTOR; SARCODONIN; SCABRONINE A; SCABRONINE D; SCABRONINE G; STRIATIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; CYATHANE; DITERPENE;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; BASIDIOMYCETES; BIOLOGICAL ACTIVITY; CYATHUS; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; HERICIUM; MICROBIAL ACTIVITY; NERVE FIBER GROWTH; NONHUMAN; PC12 CELL LINE; PHELLODON; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SARCODON; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; ISOLATION AND PURIFICATION; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BASIDIOMYCOTA; BIOLOGICAL PRODUCTS; DITERPENES; MOLECULAR STRUCTURE; NERVE GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84937053752     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150521091333     Document Type: Article

References (110)

1. Rai, M.; Tidke, G.; Wasser, S.P. Therapeutic potential of mushrooms. Nat. Prod. Rad., 2005, 4, 246-257.
2. Kawagishi, H.; Zhuang, C. Bioactive compounds from mushrooms. Heterocycles, 2007, 72, 45-52.
3. Gershenzon, J.; Dudareva, N. The function of terpene natural products in the natural world. Nat. Chem. Biol., 2007, 3, 408-414.
4. Liu, J.K. N-Containing compounds of macromycetes. Chem. Rev. 2005, 105, 2723-2744.
5. Schueffler, A.; Anke, T. Secondary Metabolites of Basidiomycetes. In: The Mycota: Physiology and Genetics XV, Anke, T.; Weber, E.; Eds. Springer: Berlin, Heidelberg 2009, pp. 2009-2231.
6. Ayer, W.A.; Browne, L.M. Terpenoid metabolites of mushrooms and related basidiomycetes. Tetrahedron, 1981, 37, 2197-2248.
7. Novak, R.; Shlaes, D.M. The pleuromutilin antibiotics: a new class for human use. Curr. Opin. Investig. Drugs, 2010, 11, 182-191.
8. Paterson, R.R. Ganoderma - a therapeutic fungal biofactory. Phytochemistry, 2006, 67, 1985-2001.
9. Abraham, W.R. Bioactive sesquiterpenes produced by fungi: are they useful for humans as well? Curr. Med. Chem., 2001, 8, 583-606.
10. Gao, J.M. New biologically active metabolites from Chinese higher fungi. Curr. Org. Chem., 2006, 10, 849-871.
11. Zaidman, B.Z.; Yassin, M.; Mahajna, J.; Wasser, S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl. Microbiol. Biotechnol., 2005, 67, 453-468.
12. Zhong, J.J.; Xiao, J.H. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv. Biochem. Eng. Biotechnol., 2009, 113, 79-150.
13. Shen, J.W.; Ruan, Y.; Ma, B.J. Diterpenoids of macromycetes. J. Basic Microbiol., 2009, 49, 242-255.
14. Cassidy, M.P.; Ghisalberti, E.L. New terpene hydrocarbons from the sponge Higginsia sp. J. Nat. Prod., 1993, 56, 1190-1193.
15. Xu, J.; Lacoske, M.H.; Theodorakis, E.A. Neurotrophicnatural products: chemistry and biology. Angew. Chem. Int. Ed. Engl., 2014, 53, 956-987.
16. Krzyczkowshi, W.; Malinowska, E.; Herold, F. The structure, medicinal properties and biosynthesis of cyathane diterpenoids. Biotechnologia, 2008, 1, 146-147.
17. 3, members of a new group of diterpenoids. Tetrahedron Lett., 1972, 13, 1917-1920.
18. Allbutt, A.D.; Ayer, W.A.; Brodie, H.J.; Johri, B.N.; Taube, H. Cyathin, a new antibiotic complex produced by Cyathus helenae. Can. J. Microbiol., 1971, 17, 1401-1407.
19. Johri, B.N. Biology and chemistry of cyathins. Hindustan Antibiot. Bull., 1973, 16, 9-19.
20. Ayer, W.; Taube, H. Metabolites of Cyathus helenae. A new class of diterpenoids. Can. J. Chem., 1973, 51, 3842-3854.
21. 3. Can. J. Chem., 1973, 51, 3157-3160.
22. Ayer, W.; Browne, L.; Mercer, J.; Taylor, D.; Ward, D. Metabolites of bird's nest fungi. Part 8. Some minor metabolites of Cyathus helenae and some correlations among the cyathins. Can. J. Chem., 1978, 56, 717-721.
23. Ayer, W.; Yoshida, T.; van Schie, D. Metabolites of bird's nest fungi. Part 9. Diterpenoid metabolites of Cyathus africanus Brodie. Can. J. Chem., 1978, 56, 2113-2120.
24. 3. Org. Lett., 2000, 2, 2125-2127.
25. 3. Can. J. Chem., 2004, 82, 254-267.
26. 3. Org. Lett., 2007, 9, 2843-2846.
27. Ayer, W.A.; Lee, S.P. Metabolites of bird's nest fungi. Part 11. Diterpenoid metabolites of Cyathus earlei Lloyd. Can. J. Chem., 1979, 57, 3332-3337.
28. Brewster, J.H. Some applications of the conformational dissymmetry rule. Tetrahedron, 1961, 13, 106-122.
29. 2. Org. Lett., 2004, 6, 4897-4900.
30. 2. J. Am. Chem. Soc., 2005, 127, 10259-10268.
31. 2. J. Am. Chem. Soc., 2005, 127, 2844-2845.
32. 2. Angew. Chem. Int. Ed. Engl., 2009, 48, 5334-5336.
33. 3, a small-molecule inducer of nerve growth factor. J. Ind. Microbiol. Biotechnol., 2011, 38, 607-615.
34. Shiono, Y.; Hiramatsu, F.; Murayama, T.; Koseki, T.; Funakoshi, T. Two cyathane-type diterpenoids from the liquid culture of Strobilurus tenacellus. Chem. Biodivers., 2008, 5, 1811-1816.
35. Han, J.; Chen, Y.; Bao, L.; Yang, X.; Liu, D.; Li, S.; Zhao, F.; Liu, H. Anti-inflammatory and cytotoxic cyathane diterpenoids from the medicinal fungus Cyathus africanus. Fitoterapia, 2013, 84, 22-31.
36. Xu, Z.; Yan, S.; Bi, K.; Han, J.; Chen, Y.; Wu, Z.; Chen, Y.; Liu, H. Isolation and identification of a new anti-inflammatory cyathane diterpenoid from the medicinal fungus Cyathus hookeri Berk. Fitoterapia, 2013, 86, 159-162.
37. Wang, B.; Han, J.; Xu, W.; Chen, Y.; Liu H. Production of bioactive cyathane diterpenes by a bird's nest fungus Cyathus gansuensis growing on cooked rice. Food Chem., 2014, 152, 169-176.
38. Lee, E.W.; Shizuki, K.; Hosokawa, S.; Suzuki, M.; Suganuma, H.; Inakuma, T.; Li, J.; Ohnishi-Kameyama, M.; Nagata, T.; Furukawa, S.; Kawagish, H. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci. Biotechnol. Biochem., 2000, 64, 2402-2405.
39. Kenmoku, H.; Kato, N.; Shimada, M.; Omoto, M.; Mori, A.; Mitsuhashi, W.; Sassa, T. Isolation of (-)-cyatha-3,12-diene, a common biosynthetic intermediate of cyathane diterpenoids, from an erinacine-producing basidiomycete, Hericium erinaceum, and its formation in a cell-free system. Tetrahedron Lett., 2001, 42, 7439-7442.
40. Ayer, W.A.; Lee, S.P.; Nakashima, T.T. Metabolites of bird's nest fungi. Part 12. Studies on the biosynthesis of the cyathins. Can. J. Chem., 1979, 57, 3338-3343.
41. 3, new cyathane metabolites from an erinacine Q-producing Hericium erinaceum. Biosci. Biotechnol. Biochem., 2004, 68, 1786-1789.
42. Kawagishi, H.; Kojima, F.; Okamoto, K.; Sakamoto, H.; Ishiguro, Y. A cyathane derivative, and agents to induce the production of nerve growth factor and antibacterial agents for food. JP 7069961 1995.
43. Shibata, H.; Tokunaga, T.; Karasawa, D.; Hirota, A.; Nakayama, M.; Nozaki, H.; Tada, T. Isolation and characterization of new bitter diterpenoids from the fungus Sarcodon scabrosus. Agric. Biol. Chem., 1989, 53, 3373-3375.
44. Ma, B.J.; Liu, J.K. A new bitter diterpenoid from Sarcodon scabrosus. J. Basic. Microbiol., 2005, 45, 328-330.
45. Dong, M.; Chen, S.P.; Kita, K.; Ichimura, Y.; Guo, W.Z.; Lu, S.; Sugaya, S.; Hiwasa, T.; Takiguchi, M.; Mori, N.; Kashima, A.; Morimura, K.; Hirota, M.; Suzuki, N. Anti-proliferative and apoptosisinducible activity of sarcodonin G from Sarcodon scabrosus in HeLa cells. Int. J. Oncol., 2009, 34, 201-207.
46. Hirota, M.; Morimura, K.; Shibata, H. Anti-inflammatory compounds from the bitter mushroom, Sarcodon scabrosus. Biosci. Biotechnol. Biochem., 2002, 66, 179-184.
47. Kamo, T.; Imura, Y.; Hagio, T.; Makabe, H.; Shibata, H.; Hirota, M. Anti-inflammatory cyathane diterpenoids from Sarcodon scabrosus. Biosci. Biotechnol. Biochem., 2004, 68, 1362-1365.
48. Ohta, T.; Kita, T.; Kobayashi, N.; Obara, Y.; Nakahata, N.; Ohizumi, Y.; Takaya, Y.; Oshima, Y. Scabronine A, a novel diterpenoid having potent inductive activity of the nerve growth factor synthesis, isolated from the mushroom, Sarcodon scabrosus. Tetrahedron Lett., 1998, 39, 6229-6232.
49. Kita, T.; Takaya, Y.; Oshima Tomihisa, Y. Scabronines B, C, D, E and F, novel diterpenoids showing stimulating activity of nerve growth factor-synthesis, from the mushroom Sarcodon scabrosus. Tetrahedron, 1998, 54, 11877-11886.
50. Obara, Y.; Nakahata, N.; Kita, T.; Takaya, Y.; Kobayashi, H.; Hosoi, S.; Kiuchi, F.; Ohta, T.; Oshima, Y.; Ohizumi, Y. Stimulation of neurotrophic factor secretion from 1321N1 human astrocytoma cells by novel diterpenoids, scabronines A and G. Eur. J. Pharmacol., 1999, 370, 79-84.
51. Ohta, T.; Kobayashi, H.; Hosoi, S.; Kiuchi, F.; Kita, T.;Takaya, Y.; Oshima, Y.; Y. Obara, Y.; Nakahata, N.; Ohizumi, Y. Stereostructures for diterpenoids having inductive activity on the nave growth factor synthesis from Sarcodon scabrosus. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 1998, 40, 341-346.
52. Waters, S.P.; Tian, Y.; Li, Y.M.; Danishefsky, S.J. Total synthesis of (-)-scabronine G, an inducer of neurotrophic factor production. J. Am. Chem. Soc., 2005, 27, 13514-13515.
53. Kobayakawa, Y.; Nakada, M. Total syntheses of (-)-scabronines G and A, and (-)-episcabronine A. Angew. Chem. Int. Ed. Engl., 2013, 52, 7569-7573.
54. Ma, B.J.; Zhu, H.J.; Liu, J.K. Isolation and characterization of new bitter diterpenoids from the basidiomycete Sarcodon scabrosus. Helv. Chim. Acta, 2004, 87, 2877-2881.
55. Ma, B.J.; Wu, T.T.; Ruan, Y.; Shen, J.W.; Zhou, H.; Yu, H.Y.; Zhao, X. Antibacterial and antifungal activity of scabronine G and H in vitro. Mycology, 2010, 1, 200-203.
56. Shi, X.W.; Liu, L.; Gao, J.M.; Zhang, A.L. Cyathane diterpenes from Chinese mushroom Sarcodon scabrosus and their neurite outgrowth-promoting activity. Eur. J. Med. Chem., 2011, 46, 3112-3117.
57. Shi, X.W.; Zhang, A.L.; Pescitelli, G.; Gao, J.M. Secoscabronine M, a novel diterpenoid from the Chinese bitter mushroom Sarcodon scabrosus. Chirality, 2012, 24, 386-390.
58. Liu, L.; Shi, X.W.; Zong, S.C.; Tang, J.J.; Gao, J.M. Scabronine M, a novel inhibitor of NGF-induced neurite outgrowth from PC12 cells from the fungus Sarcodon scabrosus. Bioorg. Med. Chem. Lett., 2012, 22, 2401-2406.
59. Shibata, H.; Irie, A.; Morita, Y. New antibacterial diterpenoids from the Sarcodon scabrosus fungus. Biosci. Biotechnol. Biochem., 1998, 62, 2450-2452.
60. Curini, M.; Maltese, F.; Marcotullio, M.C.; Menghini, L.; Pagiotti, R.; Rosati, O.; Altinier, G.; Tubaro, A. Glaucopines A and B, new cyathane diterpenes from the fruiting bodies of Sarcodon glaucopus. Planta Med., 2005, 71, 194-196.
61. Marcotullio, M.C.; Pagiotti, R.; Campagna, V.; Maltese, F.; Fardella, G.; Altinier, G.; Tubaro, A. Glaucopine C, a new diterpene from the fruiting bodies of Sarcodon glaucopus. Nat. Prod. Res., 2006, 20, 917-921.
62. Marcotullio, M.C.; Pagiott, R.; Maltese, F.; Obara, Y.; Hoshino, T.; Nakahata, N.; Curini, M. Neurite outgrowth activity of cyathane diterpenes from Sarcodon cyrneus, cyrneines A and B. Planta Med., 2006, 72, 819-823.
63. Marcotullio, M.C.; Pagiotti, R.; Maltese, F.; Oball-Mond Mwankie, G.N.; Hoshino, T.; Obara, Y.; Nakahata, N. Cyathane diterpenes from Sarcodon cyrneus and evaluation of their activities of neuritegenesis and nerve growth factor production. Bioorg. Med. Chem., 2007, 15, 2878-2882.
64. Marcotullio, M.C.; Pagiotti, R.; Campagna, V.; Maltese, F.; Fardella, G.; Altinier, G.; Tubaro, A. Glaucopine C, a new diterpene from the fruiting bodies of Sarcodon glaucopus. Nat. Prod. Res., 2006, 20, 917-921.
65. Marcotullio, M.C.; Rosati, O.; Maltese, F.; Messina, F. Cyrneine E, a new cyathane diterpene from Sarcodon cyrneus. Rec. Nat. Prod., 2013, 7, 239-241.
66. Elamparuthi, E.; Fellay, C.; Neuburger, M.; Gademann, K. Total synthesis of cyrneine A. Angew. Chem. Int. Ed. Engl., 2012, 51, 4071-4073.
67. Fang, S.T.; Zhang, L.; Li, Z.H.; Li, B.; Liu, J.K. Cyathane diterpenoids and nitrogenous terphenyl derivative from the fruiting bodies of basidiomycete Phellodon niger. Chem. Pharm. Bull., 2010, 58, 1176-1179.
68. Fang, S.T.; Feng, T.; Zhang, L.; Dong, Z.J.; Li, Z.H.; Liu, J.K. Cyathane diterpenoids from fruiting bodies of Phellodon niger. Nat. Prod. Bioprospect., 2011, 1, 37-40.
69. Wang, X.N.; Du, J.C.; Tan, R.X.; Liu, J.K. Chemical constituents of basidiomycete Hydnum repandum. Chin. Trad. Herbal Drugs, 2005, 36, 1126-1130.
70. Du, J.C.; Wang, X.N.; Tan, R.X.; Liu, J.K. Chemical constituents of basidiomycete Coltricium nitidum. Chin. Trad. Herbal Drugs, 2006, 37, 1297-1300.
71. Anke, T.; Oberwinkler, F.; Steglich, W.; Hofle, G. The striatins-new antibiotics from the Basidiomycete Cyathus striatus (Huds. ex Pers.) willd. J. Antibiot., 1977, 30, 221-225.
72. Hecht, H.J.; Hofle, G.; Steglich, W.; Anke, T.; Oberwinkler, F. Striatin A, B, and C: novel diterpenoid antibiotics from Cyathus striatus; X-ray crystal structure of striatin A. J. Chem. Soc., Chem. Commun., 1978, 665-666.
73. Steglich, W. Biologically active compounds from higher fungi. Pure Appl. Chem., 1981, 53, 1233-1240.
74. Anke, T.; Steglich W. Neue Wirkstoffe aus Basidiomyceten. Forum Mikrobiol., 1988, 11, 21-25.
75. Anke, T.; Rabe, U.; Schu, P.; Eizenhöfer, T.; Schrage, M.; Steglich, W. Studies on the biosynthesis of striatal-type diterpenoids and the biological activity of herical. Z. Naturforsch C., 2002, 57, 263-271.
76. Kawagishi, H.; Shimada, A.; Shirai, R.; Okamoto, K.; Ojima, F.; Sakamoto, H.; Ishiguro, Y.; Furukawa, S. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett., 1994, 35, 1569-1572.
77. Kawagishi, H.; Simada, A.; Shizuki, K.; Mori, H.; Okamoto, K.; Sakamoto, H.; Furukawa, S. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. Heterocycl. Commun., 1996, 2, 51-54.
78. Kawagishi, H.; Shimada, A.; Hosokawa, S.; Mori, H.; Sakamoto, H.; Ishiguro, Y.; Sakemi, S.; Bordner, J.; Kojima, N.; Furukawa, S. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)- synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett., 1996, 37, 7399-7402.
79. Kenmoku, H.; Sassa, T.; Kato, N. Isolation of erinacine P, a new parental metabolite of cyathane-xylosides, from Hericium erinaceum and its biomimetic conversion into erinacines A and B. Tetrahedron Lett., 2000, 41, 4389-4393.
80. Kenmoku, H.; Shimai, T.; Toyomasu, T.; Kato, N.; Sassa, T. Erinacine Q, a new erinacine from Hericium erinaceum, and its biosynthetic route to erinacine C in the basidiomycete. Biosci. Biotechnol. Biochem., 2002, 66, 571-575.
81. Ma, B.J.; Zhou, Y.; Li, L.Z.; Li, H.M.; Gao, Z.M.; Ruan, Y. A new cyathane-xyloside from the mycelia of Hericium erinaceum. Z. Naturforsch., 2008, 63b, 1241-1242.
82. Steglich, W.; Eizenhofer, T.; Casser, I.; Steffan, B.; Rabe, U.; Boker, R.; Knerr, H.J.; Anke, H.; Anke, T. Untersuchungen zur Biosynthese von Wirkstoffen aus Pilzkulturen. Dechema Monogr., 1993, 129, 3-13.
83. Watanabe, H.; Takano, M.; Umino, A.; Ito, T.; Ishikawa, H.; Nakada, M. Enantioselective total synthesis of (-)-erinacine B. Org. Lett., 2007, 9, 359-362.
84. Watanabe, H.; Nakada, M. Biomimetic total synthesis of (-)-erinacine E. J. Am. Chem. Soc., 2008, 130, 1150-1151.
85. Krzyczkowski, W.; Malinowska, E.; Herold, F. Erinacine A biosynthesis in submerged cultivation of Hericium erinaceum: quantification and improved cultivation. Eng. Life Sci., 2010, 10, 446-457.
86. Saito, T.; Aoki, F.; Hirai, H.; Inagaki, T.; Matsunaga, Y.; Sakakibara, T.; Sakemi, S.; Suzuki, Y.; Watanabe, S.; Suga, O.; Sujaku, T.; Smogowicz, A.A.; Truesdell, S.J.; Wong, J.W.; Nagahisa, A.; Kojima, Y.; Kojima, N. Erinacine E as a kappa opioid receptor agonist and its new analogs from a Basidiomycete, Hericium ramosum. J. Antibiot., 1998, 51, 983-990.
87. Kawagishi, H.; Masui, A.; Tokuyama, S.; Nakamura, T. Erinacines J and K from the mycelia of Hericium erinaceum. Tetrahedron, 2006, 62, 8463-8466.
88. Shimada, A.; Kawagishi, H.; Furukawa, S.; Mori, Y.; Kojima, F.; Okamoto, K.; Sakamoto, H. Cyathanes from Hericium erinaceum and NGF formation promoters containing them. JP 2,005,239,669 2005.
89. Wright, D.L.; Whitehead, C.R. Recent progress on the synthesis of cyathane type diterpenes. Org. Prep. Proced. Int., 2000, 32, 309-330.
90. 2, (-)-erinacine B, and (-)-erinacine E. J. Synth. Org. Chem. Jpn., 2008, 66, 1116-1125.
91. Enquist Jr, J.A.; Stoltz, B.M. Synthetic efforts toward cyathane diterpenoid natural products. Nat. Prod. Rep., 2009, 26, 661-680.
92. Nakada, M. Enantioselective total syntheses of cyathane diterpenoids. Chem. Rec., 2014, 14, 641-662.
93. Leung, G.Y.C.; Li, H.; Toh, Q.Y.; Ng, A.M.Y.; Sum, R.J.; Bandow, J.E.; Chen, D.Y.K. Total synthesis and biological evaluation of the Fab-inhibitory antibiotic platencin and analogues thereof. Eur. J. Org. Chem., 2011, 2011(1), 183-196.
94. 4. Org. Lett., 2010, 12, 1552-1555.
95. Wilson, R.M.; Danishefsky S.J. Applications of total synthesis to problems in neurodegeneration: fascinating chemistry along the way. Acc. Chem. Res. 2006, 39, 539-549.
96. Danishefsky, S.J.; Waters, S.P. Synthesis of scabronines and analogues thereof. US 20090186940, 2009.
97. Ford, M.J.; Knight, J.G.; Ley, S.V.; Vile, S. Total synthesis of avermectin B1a: synthesis of the carbohydrate bis-oleandrose fragment and coupling to the avermectin B1a aglycone. Synlett, 1990, 1990(6), 331-332.
98. Kobayakawa, Y.; Nakada, M. Enantioselective total synthesis of (-)-scabronine D. Heterocycles, 2014, 89, 669-677.
99. 3). Synlett, 1991, 1991(4), 273-275.
100. Drège, E.; Tominiaux, C.; Morgant, G.; Desmae¨le, D. Synthetic studies on cyathin terpenoids: enantioselective synthesis of the tricyclic core of cyathin through intramolecular Heck cyclisation. Eur. J. Org. Chem., 2006, 2006, 4825-4840.
101. Baillargeon, P.V.; Stille, K.J. Palladium-catalyzed formylation of organic halides with carbon monoxide and tin hydride. J. Am. Chem. Soc., 1986, 108, 452-461.
102. 2. J. Antibiot., 2014, 67, 483-485.
103. Kirik, D.; Georgievska, B.; Bjorklund, A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat. Neurosci. 2004, 7, 105-110.
104. Obara, Y. Development of anti-dementia drugs related to neurotrophic factors. Yakugaku Zasshi, 2006, 126, 747-755.
105. Obara, Y.; Kobayashi, H.; Ohta, T.; Ohizumi, Y.; Nakahata, N. Scabronine G-methylester enhances secretion of neurotrophic factors mediated by an activation of protein kinase C-zeta. Mol. Pharmacol., 2001, 59, 1287-1297.
106. Shimbo, M.; Kawagishi, H.; Yokogoshi, H. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats. Nutr. Res., 2005, 25, 617-623.
107. Obara, Y.; Hoshino, T.; Marcotullio, M.C.; Pagiotti, R.; Nakahata, N. A novel cyathane diterpene, cyrneine A, induces neurite outgrowth in a Rac1-dependent mechanism in PC12 cells. Life Sci., 2007, 80, 1669-1677.
108. Dong, M.; Wang, G.; Guo, W.Z.; Sun, Z.; Hirota, M.; Cong, B. Antitumor activity and mechanism of the compound from Sarcodon scabrosus karst. Nat. Prod. Res. Dev., 2007, 19, 88-91.
109. Suzuki, N.; Kita, K.; Dong, M.; Hirota, M.; Morimura, K. Anticancer agent comprising cyathane derivative. WO 2007123027 2007.
110. Inchausti, A.; Yaluff, G.; Rojas de Arias, A.; Torres, S.; Ferreira, M.E.; Nakayama, H.; Schinini, A.; Lorenzen, K.; Anke, T.; Fournet, A. Leishmanicidal and trypanocidal activity of extracts and secondary metabolites from basidiomycetes. Phytother. Res., 1997, 11, 193-197.